D
A. Fahandej-Sadi, R. J. Lundgren
Letter
Synlett
58, 8315. (e) Zhou, Y.; Wang, J.; Gu, Z.; Wang, S.; Zhu, W.; Acena,
J. L.; Soloshonok, V. A.; Izawa, K.; Liu, H. Chem. Rev. 2016, 116,
422.
O
[B]
Br
O
F
(2) (a) Liang, T.; Neumann, C. N.; Ritter, T. Angew. Chem. Int. Ed.
2013, 52, 8214. (b) Champagne, P. A.; Desroches, J.; Hamel, J. D.;
Vandamme, M.; Paquin, J. F. Chem. Rev. 2015, 115, 9073.
(c) Yang, X. Y.; Wu, T.; Phipps, R. J.; Toste, F. D. Chem. Rev. 2015,
115, 826.
50 mol% Cu(OTf)2
R
F
R
NEt3, DMA
r.t., air
CO2H
Br
O
O
O
Me
(3) (a) Gray, E. E.; Nielsen, M. K.; Choquette, K. A.; Kalow, J. A.;
Graham, T. J.; Doyle, A. G. J. Am. Chem. Soc. 2016, 138, 10802.
(b) Lee, S. Y.; Neufeind, S.; Fu, G. C. J. Am. Chem. Soc. 2014, 136,
8899. (c) Li, F. Y.; Wu, Z. J.; Wang, J. Angew. Chem. Int. Ed. 2015,
54, 656. (d) Paull, D. H.; Scerba, M. T.; Alden-Danforth, E.;
Widger, L. R.; Lectka, T. J. Am. Chem. Soc. 2008, 130, 17260.
(4) For example, see the supporting information section of:
Verhoog, S.; Pfeifer, L.; Khotavivattana, T.; Calderwood, S.;
Collier, T. L.; Wheelhouse, K.; Tredwell, M.; Gouverneur, V.
Synlett 2016, 27, 25.
F
F
F
Me
O
BnO
F3C
O
CO2H
CO2H
CO2H
3a: 69%
3b: 59%
3c: 56%
O
O
F
F
O
Me
CO2H
CO2H
3d: 74%
3e: <10%
(5) Kabore, L.; Chebli, S.; Faure, R.; Laurent, E.; Marquet, B. Tetrahe-
dron Lett. 1990, 31, 3137.
(6) For a representative example, see: Audia, J. E.; Thompson, R. C.;
Wilkie, S. C.; Britton, T. C.; Porter, W. J.; Huffman, G. W.;
Latimer, L. H. Elan Pharmaceuticals, Inc., Eli Lilly and Company
Patent US6509331 B1, 2003.
(7) For an improved protocol achieved by reagent development,
see: Goldberg, N. W.; Shen, X.; Li, J.; Ritter, T. Org. Lett. 2016, 18,
6102.
(8) The direct use of fluoroacetic acid is not advisable because of its
high toxicity, see: Goncharov, N. V.; Jenkins, R. O.; Radilov, A. S.
J. Appl. Toxicol. 2006, 26, 148.
Scheme 4 Scope of alternative α-fluoro carboxylic acid derivatives in
the Cu-mediated decarboxylative cross-coupling reaction with aryl bo-
ron reagents
Ar
1
– CuI
– CO2
Ar–[B]
CuII
CuIII
O
CuII
O
O
Ar
RO
– CuI
F
RO
O
transmetalation
disproportionation
reductive elimination
decarboxylation
F
(9) (a) Qing, F.-L.; Guo, C.; Yue, X. Synthesis 2010, 1837. (b) Su, Y.
M.; Feng, G. S.; Wang, Z. Y.; Lan, Q.; Wang, X. S. Angew. Chem. Int.
Ed. 2015, 54, 6003. (c) Wu, Y.; Zhang, H. R.; Cao, Y. X.; Lan, Q.;
Wang, X. S. Org. Lett. 2016, 18, 5564.
Scheme 5 Potential mechanistic steps in the Cu-mediated cross-cou-
pling of α-fluoromalonic half esters and aryl boron reagents
(10) For the Ir-catalyzed coupling with electron-rich heteroarenes,
see: Yu, W.; Xu, X.-H.; Qing, F.-L. New J. Chem. 2016, 40, 6564.
(11) Harsanyi, A.; Sandford, G.; Yufit, D. S.; Howard, J. A. Beilstein J.
Org. Chem. 2014, 10, 1213.
(12) Beare, N. A.; Hartwig, J. F. J. Org. Chem. 2002, 67, 541.
(13) (a) Moon, P. J.; Halperin, H. M.; Lundgren, R. J. Angew. Chem. Int.
Ed. 2016, 55, 1894. (b) Moon, P. J.; Yin, S.; Lundgren, R. J. J. Am.
Chem. Soc. 2016, 138, 13826. (c) Moon, P. J.; Lundgren, R. J.
Synlett 2017, 28, 515.
(14) For a review of decarboxylative carbon–carbon bond-forming
processes, see: Patra, T.; Maiti, D. Chem. Eur. J. 2017, 23, 7382.
(15) (a) Hine, J.; Mahone, L. G.; Liotta, C. L. J. Am. Chem. Soc. 1967, 89,
5911. (b) Zhang, Z.; Puente, A.; Wang, F.; Rahm, M.; Mei, Y.;
Mayr, H.; Prakash, G. K. Angew. Chem. Int. Ed. 2016, 55, 12845.
(16) Xia, T.; He, L.; Liu, Y. A.; Hartwig, J. F.; Liao, X. Org. Lett. 2017, 19,
2610.
(17) (a) King, A. E.; Ryland, B. L.; Brunold, T. C.; Stahl, S. S. Organome-
tallics 2012, 31, 7948. (b) Lam, P. Y. S. Chan–Lam Coupling Reac-
tion: Copper-promoted C–Element Bond Oxidative Coupling Reac-
mechanistic understanding of the process and expanding
the diversity of α-fluorinated acids that can be used a cou-
pling partners.
Acknowledgment
We thank NSERC (Discovery Grant to R.J.L., PGS-D fellowship to A.F.S)
and the University of Alberta for support. Patrick J. Moon is thanked
for late-stage experimental contribution and for helpful discussions.
Supporting Information
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
tion with Boronic Acids, In Synthetic Methods in Drug Discovery;1Vo.
Blakemore, D. C.; Doyle, P. M.; Fobian, Y. M., Eds.; Chapter 7; The
Royal Society of Chemistry: Cambridge, UK, 2015, pp 242–273.
(18) Huang, Z.; Hartwig, J. F. Angew. Chem. Int. Ed. 2012, 51, 1028.
(19) (a) Fortner, K. C.; Shair, M. D. J. Am. Chem. Soc. 2007, 129, 1032.
(b) Lalic, G.; Aloise, A. D.; Shair, M. D. J. Am. Chem. Soc. 2003,
125, 2852.
l
References and Notes
(1) (a) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem.
Soc. Rev. 2008, 37, 320. (b) Fujiwara, T.; O’Hagan, D. J. Fluorine
Chem. 2014, 167, 16. (c) Wang, J.; Sanchez-Rosello, M.; Acena, J.
L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.;
Liu, H. Chem. Rev. 2014, 114, 2432. (d) Gillis, E. P.; Eastman, K. J.;
Hill, M. D.; Donnelly, D. J.; Meanwell, N. A. J. Med. Chem. 2015,
© Georg Thieme Verlag Stuttgart · New York — Synlett 2017, 28, A–E